Ironwood Capital — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

IsoPlexisisoplexis.comSep 2017 · $13.5M

IsoPlexis (now part of Bruker Cellular Analysis) provides single-cell functional profiling technology used to discover therapeutic antibodies, interrogate T cells for novel cell therapies, and accelerate cell line development.

BiotechDeep TechMedical DevicesNew Haven, US

Rong Fan(Director)Sean McKay(Executive Officer, Director)Sean Mackay(Executive Officer, Director)

BoardDaniel Wagner(Director)John Conley(Director)inGregory Ho(Director)

Co-investorsConnecticut Innovations Ally Bridge Group Northpond Ventures Spring Mountain Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.